Snowball logo
logo
UK2

Shandong Weigao Group Medical Polymer Company Limited

0.66+0.02  (3.13%)
Start your journey to financial independence
Snowball will help you to track your portfolio, plan deposits to your brokerage account and increase passive income
Start

Frequently Asked Questions

What sector does Shandong Weigao Group Medical Polymer Company Limited (UK2) operate in?

Shandong Weigao Group Medical Polymer Company Limited belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.

What is Shandong Weigao Group Medical Polymer Company Limited (UK2) current stock price?

As of the latest data, Shandong Weigao Group Medical Polymer Company Limited stock price is €0.66, with a previous close of €0.64. Shandong Weigao Group Medical Polymer Company Limited gained €0.02 in the last trading session, representing a 3.13% increase.

What is Shandong Weigao Group Medical Polymer Company Limited (UK2) current market capitalization?

Shandong Weigao Group Medical Polymer Company Limited market cap is approximately 2.97 billion.

What is Shandong Weigao Group Medical Polymer Company Limited (UK2) Earnings Per Share (EPS)?

The trailing EPS is €0.05.

What is Shandong Weigao Group Medical Polymer Company Limited (UK2) Price-to-Earnings (P/E) ratio?

Shandong Weigao Group Medical Polymer Company Limited current P/E ratio is 13.2.

Does Shandong Weigao Group Medical Polymer Company Limited (UK2) dividends?

Yes. Shandong Weigao Group Medical Polymer Company Limited pays semiannual dividends with a forward yield of 0.44% and a forward payout of €0.02 per share.

When is Shandong Weigao Group Medical Polymer Company Limited (UK2) next earnings report?

Shandong Weigao Group Medical Polymer Company Limited is expected to release its next earnings report on June 30, 2025.

What is Shandong Weigao Group Medical Polymer Company Limited (UK2) beta (volatility) score?

Shandong Weigao Group Medical Polymer Company Limited has a beta of 0.593, indicating lower volatility than the overall market.